• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    SERENA-6 Trial Shows Guardant360 CDx Test Value in Breast Cancer

    BUSINESSWIRE

    Camizestrant Reduced Risk of Disease Progression or Death by 56%

    BUSINESSWIRE

    Camizestrant Cuts Risk 56% In ESR1+ HR+ Breast Cancer Trial

    BUSINESSWIRE

    AstraZeneca Posts Positive Ph 3 Results for Oral Breast Cancer Drug

    PRESS RELEASE

    AZ eyes China`s `explosion` of innovation for cell therapy

    FIERCE BIOTECH

    Camizestrant delayed disease progression in advanced ER-positive breast cancer

    PRESS RELEASE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.